sar425899 sanofi dual agonist glp-1 glucagon Peptide-based GLP-1/glucagon co-agonists: A double-edged sword to combat diabesity What Are Glucagon-Like Peptide-1 (GLP-1)

When rats received BPC-157 before induced liver injury, all treated groups showed reduced liver enzymes and bilirubin compared to controls suggesting protective rather than toxic effects on the liver

Treatment with orforglipron, an oral glucagon like peptide-1 receptor agonist, is associated with improvements of CV risk biomarkers in participants with type 2 diabetes or obesity without diabetes

The ACOG 2024 Contraception in Women With Obesity guideline recommends intrauterine devices or subdermal implants as first-line options in patients receiving weight-loss pharmacotherapy who do not desire pregnancy

Research has shown its ability to help skin burns heal at a faster rate by increasing blood flow to damaged tissues